Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.

MLA

Mazella, Jean, et al. “Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design.” PLoS Biology, vol. 8, no. 4, Apr. 2010, p. e1000355. EBSCOhost, https://doi.org/10.1371/journal.pbio.1000355.

APA

Mazella, J., Pétrault, O., Lucas, G., Deval, E., Béraud-Dufour, S., Gandin, C., El-Yacoubi, M., Widmann, C., Guyon, A., Chevet, E., Taouji, S., Conductier, G., Corinus, A., Coppola, T., Gobbi, G., Nahon, J.-L., Heurteaux, C., & Borsotto, M. (2010). Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biology, 8(4), e1000355. https://doi.org/10.1371/journal.pbio.1000355

Chicago

Mazella, Jean, Olivier Pétrault, Guillaume Lucas, Emmanuel Deval, Sophie Béraud-Dufour, Carine Gandin, Malika El-Yacoubi, et al. 2010. “Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design.” PLoS Biology 8 (4): e1000355. doi:10.1371/journal.pbio.1000355.